ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enbrel (Etanercept) and Biosimilar Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33H14580
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enbrel Etanercept Biosimilar Market Research Report 2023
BUY CHAPTERS

Global Enbrel (Etanercept) and Biosimilar Market Research Report 2025

Code: QYRE-Auto-33H14580
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Samsung Bioepis
3S Bio
Novartis
Lupin Ltd
Pfizer Inc
Amgen Inc

Enbrel (Etanercept) and Biosimilar Market Size

The global market for Enbrel (Etanercept) and Biosimilar was valued at US$ 7256 million in the year 2024 and is projected to reach a revised size of US$ 9079 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Enbrel (Etanercept) and Biosimilar Market

Enbrel (Etanercept) and Biosimilar Market

Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
North American market for Enbrel (Etanercept) and Biosimilar is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Enbrel (Etanercept) and Biosimilar is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Enbrel (Etanercept) and Biosimilar include Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio, Lupin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enbrel (Etanercept) and Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enbrel (Etanercept) and Biosimilar.
The Enbrel (Etanercept) and Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enbrel (Etanercept) and Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enbrel (Etanercept) and Biosimilar manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enbrel (Etanercept) and Biosimilar Market Report

Report Metric Details
Report Name Enbrel (Etanercept) and Biosimilar Market
Accounted market size in year US$ 7256 million
Forecasted market size in 2031 US$ 9079 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Syringe
  • Pen
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio, Lupin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Enbrel (Etanercept) and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Enbrel (Etanercept) and Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Enbrel (Etanercept) and Biosimilar Market growing?

Ans: The Enbrel (Etanercept) and Biosimilar Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Enbrel (Etanercept) and Biosimilar Market size in 2031?

Ans: The Enbrel (Etanercept) and Biosimilar Market size in 2031 will be US$ 9079 million.

Who are the main players in the Enbrel (Etanercept) and Biosimilar Market report?

Ans: The main players in the Enbrel (Etanercept) and Biosimilar Market are Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio, Lupin

What are the Application segmentation covered in the Enbrel (Etanercept) and Biosimilar Market report?

Ans: The Applications covered in the Enbrel (Etanercept) and Biosimilar Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Enbrel (Etanercept) and Biosimilar Market report?

Ans: The Types covered in the Enbrel (Etanercept) and Biosimilar Market report are Syringe, Pen

Recommended Reports

Biosimilars Market

Rheumatology & Arthritis

Autoimmune Disease Therapy

1 Enbrel (Etanercept) and Biosimilar Market Overview
1.1 Product Definition
1.2 Enbrel (Etanercept) and Biosimilar by Type
1.2.1 Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2024 VS 2031)
1.2.2 Syringe
1.2.3 Pen
1.3 Enbrel (Etanercept) and Biosimilar by Application
1.3.1 Global Enbrel (Etanercept) and Biosimilar Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Enbrel (Etanercept) and Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Enbrel (Etanercept) and Biosimilar Revenue 2020-2031
1.4.2 Global Enbrel (Etanercept) and Biosimilar Sales 2020-2031
1.4.3 Global Enbrel (Etanercept) and Biosimilar Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Enbrel (Etanercept) and Biosimilar Market Competition by Manufacturers
2.1 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Manufacturers (2020-2025)
2.2 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Enbrel (Etanercept) and Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Product Type & Application
2.7 Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Date of Enter into This Industry
2.8 Global Enbrel (Etanercept) and Biosimilar Market Competitive Situation and Trends
2.8.1 Global Enbrel (Etanercept) and Biosimilar Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enbrel (Etanercept) and Biosimilar Players Market Share by Revenue
2.8.3 Global Enbrel (Etanercept) and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enbrel (Etanercept) and Biosimilar Market Scenario by Region
3.1 Global Enbrel (Etanercept) and Biosimilar Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2020-2031
3.2.1 Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2020-2025
3.2.2 Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2026-2031
3.3 Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2020-2031
3.3.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2020-2025
3.3.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2026-2031
3.4 North America Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country
3.4.1 North America Enbrel (Etanercept) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2031)
3.4.3 North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country
3.5.1 Europe Enbrel (Etanercept) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2031)
3.5.3 Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Region
3.6.1 Asia Pacific Enbrel (Etanercept) and Biosimilar Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Region (2020-2031)
3.6.3 Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Enbrel (Etanercept) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2031)
3.7.3 Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Enbrel (Etanercept) and Biosimilar Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2031)
3.8.3 Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2020-2031)
4.1.1 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2020-2025)
4.1.2 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2026-2031)
4.1.3 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2020-2031)
4.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2020-2031)
4.2.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2020-2025)
4.2.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2026-2031)
4.2.3 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2020-2031)
4.3 Global Enbrel (Etanercept) and Biosimilar Price by Type (2020-2031)
5 Segment by Application
5.1 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2020-2031)
5.1.1 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2020-2025)
5.1.2 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2026-2031)
5.1.3 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2020-2031)
5.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2020-2031)
5.2.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2020-2025)
5.2.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2026-2031)
5.2.3 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2020-2031)
5.3 Global Enbrel (Etanercept) and Biosimilar Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Enbrel (Etanercept) and Biosimilar Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Samsung Bioepis
6.3.1 Samsung Bioepis Company Information
6.3.2 Samsung Bioepis Description and Business Overview
6.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product Portfolio
6.3.5 Samsung Bioepis Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Enbrel (Etanercept) and Biosimilar Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 3s Bio
6.5.1 3s Bio Company Information
6.5.2 3s Bio Description and Business Overview
6.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Product Portfolio
6.5.5 3s Bio Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Company Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lupin Enbrel (Etanercept) and Biosimilar Product Portfolio
6.6.5 Lupin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enbrel (Etanercept) and Biosimilar Industry Chain Analysis
7.2 Enbrel (Etanercept) and Biosimilar Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enbrel (Etanercept) and Biosimilar Production Mode & Process Analysis
7.4 Enbrel (Etanercept) and Biosimilar Sales and Marketing
7.4.1 Enbrel (Etanercept) and Biosimilar Sales Channels
7.4.2 Enbrel (Etanercept) and Biosimilar Distributors
7.5 Enbrel (Etanercept) and Biosimilar Customer Analysis
8 Enbrel (Etanercept) and Biosimilar Market Dynamics
8.1 Enbrel (Etanercept) and Biosimilar Industry Trends
8.2 Enbrel (Etanercept) and Biosimilar Market Drivers
8.3 Enbrel (Etanercept) and Biosimilar Market Challenges
8.4 Enbrel (Etanercept) and Biosimilar Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Samsung Bioepis
3S Bio
Novartis
Lupin Ltd
Pfizer Inc
Amgen Inc
List of Tables
 Table 1. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Enbrel (Etanercept) and Biosimilar Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Enbrel (Etanercept) and Biosimilar Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Enbrel (Etanercept) and Biosimilar Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Enbrel (Etanercept) and Biosimilar Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Enbrel (Etanercept) and Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Product Type & Application
 Table 12. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Enbrel (Etanercept) and Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enbrel (Etanercept) and Biosimilar as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Enbrel (Etanercept) and Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Enbrel (Etanercept) and Biosimilar Sales by Region (2020-2025) & (K Units)
 Table 18. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2020-2025)
 Table 19. Global Enbrel (Etanercept) and Biosimilar Sales by Region (2026-2031) & (K Units)
 Table 20. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2026-2031)
 Table 21. Global Enbrel (Etanercept) and Biosimilar Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2020-2025)
 Table 23. Global Enbrel (Etanercept) and Biosimilar Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2026-2031)
 Table 25. North America Enbrel (Etanercept) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2025) & (K Units)
 Table 27. North America Enbrel (Etanercept) and Biosimilar Sales by Country (2026-2031) & (K Units)
 Table 28. North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Type (2020-2025)
 Table 51. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Type (2026-2031)
 Table 52. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2020-2025)
 Table 53. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2026-2031)
 Table 54. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2020-2025)
 Table 57. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2026-2031)
 Table 58. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Application (2020-2025)
 Table 61. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Application (2026-2031)
 Table 62. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2020-2025)
 Table 63. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2026-2031)
 Table 64. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2020-2025)
 Table 67. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2026-2031)
 Table 68. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Enbrel (Etanercept) and Biosimilar Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Enbrel (Etanercept) and Biosimilar Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Samsung Bioepis Company Information
 Table 81. Samsung Bioepis Description and Business Overview
 Table 82. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product
 Table 84. Samsung Bioepis Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Enbrel (Etanercept) and Biosimilar Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. 3s Bio Company Information
 Table 91. 3s Bio Description and Business Overview
 Table 92. 3s Bio Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. 3s Bio Enbrel (Etanercept) and Biosimilar Product
 Table 94. 3s Bio Recent Developments/Updates
 Table 95. Lupin Company Information
 Table 96. Lupin Description and Business Overview
 Table 97. Lupin Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lupin Enbrel (Etanercept) and Biosimilar Product
 Table 99. Lupin Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Enbrel (Etanercept) and Biosimilar Distributors List
 Table 103. Enbrel (Etanercept) and Biosimilar Customers List
 Table 104. Enbrel (Etanercept) and Biosimilar Market Trends
 Table 105. Enbrel (Etanercept) and Biosimilar Market Drivers
 Table 106. Enbrel (Etanercept) and Biosimilar Market Challenges
 Table 107. Enbrel (Etanercept) and Biosimilar Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Enbrel (Etanercept) and Biosimilar
 Figure 2. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Enbrel (Etanercept) and Biosimilar Market Share by Type: 2024 & 2031
 Figure 4. Syringe Product Picture
 Figure 5. Pen Product Picture
 Figure 6. Global Enbrel (Etanercept) and Biosimilar Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Enbrel (Etanercept) and Biosimilar Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Enbrel (Etanercept) and Biosimilar Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Enbrel (Etanercept) and Biosimilar Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Enbrel (Etanercept) and Biosimilar Sales (2020-2031) & (K Units)
 Figure 14. Global Enbrel (Etanercept) and Biosimilar Average Price (US$/Unit) & (2020-2031)
 Figure 15. Enbrel (Etanercept) and Biosimilar Report Years Considered
 Figure 16. Enbrel (Etanercept) and Biosimilar Sales Share by Manufacturers in 2024
 Figure 17. Global Enbrel (Etanercept) and Biosimilar Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Enbrel (Etanercept) and Biosimilar Players: Market Share by Revenue in Enbrel (Etanercept) and Biosimilar in 2024
 Figure 19. Enbrel (Etanercept) and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Enbrel (Etanercept) and Biosimilar Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2020-2031)
 Figure 22. North America Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2020-2031)
 Figure 23. United States Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2020-2031)
 Figure 26. Europe Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2020-2031)
 Figure 34. China Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Enbrel (Etanercept) and Biosimilar by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Enbrel (Etanercept) and Biosimilar by Type (2020-2031)
 Figure 53. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Enbrel (Etanercept) and Biosimilar by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Enbrel (Etanercept) and Biosimilar by Application (2020-2031)
 Figure 56. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2020-2031)
 Figure 57. Enbrel (Etanercept) and Biosimilar Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Etanercept Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Biosimilar Market Research Report 2024
Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ustekinumab Biosimilars Market Research Report 2024
Global Adalimumab Infliximab And Etanercept Biosimilars Market Research Report 2024
Humira Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adalimumab Humira and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Remicade infliximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TNF Inhibitors for the Treatment of Rheumatoid Arthritis Market Research Report 2024
Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Research Report 2024
Global Humira Market Insights Forecast to 2030
Global Adalimumab Market Insights Forecast to 2030
Enbrel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Etanercept Solution for Injection Market Research Report 2024
Biosimilars Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Remicade Infliximab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions